Alejandro Rivero-de-Aguilar

8PUBLICATIONS
30CO-AUTHORS
Epidemiological methodsTaxation accountingPredictive and prognostic markersPharmaceutical delivery technologiesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 26, 2026
Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials.

Marta Mascareñas-García, Alejandro Rivero-de-Aguilar, Cristina Candal-Pedreira

|Jul 03, 2025
Silent protocol modifications in multiple sclerosis clinical trials: a registry-based cross-sectional study.

Alejandro Rivero-de-Aguilar, Mónica Pérez-Ríos, Joseph S Ross

|Aug 27, 2024
Discrepancies in the results reported for multiple sclerosis clinical trials: A comparison between ClinicalTrials.gov and peer-reviewed journals.

Alejandro Rivero-de-Aguilar, Mónica Pérez-Ríos, Marta Mascareñas-García

|Aug 07, 2023
Neurotological emergencies: a narrative review.

Alejandro Rivero-de-Aguilar, Andrés Soto-Varela, Marilina Puente-Hernandez

|Aug 04, 2023
Best practices in phase III clinical trials on DMTs for multiple sclerosis: a systematic analysis and appraisal of published trials.

Marta Mascarenas-Garcia, Alejandro Rivero-de-Aguilar, Mónica Pérez-Ríos

Pageof 2